Advanced search
Add to list

Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951

(2004) BLOOD. 103(2). p.442-450
Author
Organization

Citation

Please use this url to cite or link to this publication:

MLA
CAVÉ, H, S SUCIU, C PREUDHOMME, et al. “Clinical Significance of HOX11L2 Expression Linked to T(5;14)(q35;q32), of HOX11 Expression, and of SIL-TAL Fusion in Childhood T-cell Malignancies: Results of EORTC Studies 58881 and 58951.” BLOOD 103.2 (2004): 442–450. Print.
APA
CAVÉ, H., SUCIU, S., PREUDHOMME, C., Poppe, B., ROBERT, A., UYTTEBROECK, A., MALET, M., et al. (2004). Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951. BLOOD, 103(2), 442–450.
Chicago author-date
CAVÉ, H, S SUCIU, C PREUDHOMME, Bruce Poppe, A ROBERT, A UYTTEBROECK, M MALET, et al. 2004. “Clinical Significance of HOX11L2 Expression Linked to T(5;14)(q35;q32), of HOX11 Expression, and of SIL-TAL Fusion in Childhood T-cell Malignancies: Results of EORTC Studies 58881 and 58951.” Blood 103 (2): 442–450.
Chicago author-date (all authors)
CAVÉ, H, S SUCIU, C PREUDHOMME, Bruce Poppe, A ROBERT, A UYTTEBROECK, M MALET, P BOUTARD, Yves Benoit, L MAUVIEUX, P LUTZ, F MECHINAUD, N GRARDEL, F MAZINGUE, M DUPONT, G MARGUERITTE, MP PAGES, Y BERTRAND, E PLOUVIER, G BRUNIE, C BASTARD, D PLANTAZ, IV VELDE, A HAGEMEIJER, Franki Speleman, M LESSARD, J OTTEN, E VILMER, and N DASTUGUE. 2004. “Clinical Significance of HOX11L2 Expression Linked to T(5;14)(q35;q32), of HOX11 Expression, and of SIL-TAL Fusion in Childhood T-cell Malignancies: Results of EORTC Studies 58881 and 58951.” Blood 103 (2): 442–450.
Vancouver
1.
CAVÉ H, SUCIU S, PREUDHOMME C, Poppe B, ROBERT A, UYTTEBROECK A, et al. Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951. BLOOD. AMER SOC HEMATOLOGY; 2004;103(2):442–50.
IEEE
[1]
H. CAVÉ et al., “Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951,” BLOOD, vol. 103, no. 2, pp. 442–450, 2004.
@article{213539,
  author       = {CAVÉ, H and SUCIU, S and PREUDHOMME, C and Poppe, Bruce and ROBERT, A and UYTTEBROECK, A and MALET, M and BOUTARD, P and Benoit, Yves and MAUVIEUX, L and LUTZ, P and MECHINAUD, F and GRARDEL, N and MAZINGUE, F and DUPONT, M and MARGUERITTE, G and PAGES, MP and BERTRAND, Y and PLOUVIER, E and BRUNIE, G and BASTARD, C and PLANTAZ, D and VELDE, IV and HAGEMEIJER, A and Speleman, Franki and LESSARD, M and OTTEN, J and VILMER, E and DASTUGUE, N},
  issn         = {0006-4971},
  journal      = {BLOOD},
  language     = {eng},
  number       = {2},
  pages        = {442--450},
  publisher    = {AMER SOC HEMATOLOGY},
  title        = {Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951},
  volume       = {103},
  year         = {2004},
}

Web of Science
Times cited: